Investors
Opyl is headquartered in Melbourne, Australia and listed on the Australian Stock Exchange (ASX:OPL)
ASX Announcements
Opyl Director Mr Basyrov steps down
downloadNotice of 2021 Annual General Meeting
downloadOpyl to present at next week’s IRD Invest
downloadPort Jackson Securities Webinar
downloadInvestor webinar: Full year results and update on Opin, the company’s recently launched clinical trial recruitment platform
downloadOpyl’s clinical trial recruitment platform Opin enters global strategic alliance
downloadInvestor Presentations
Quarterly Reports
Opyl Appendix 4C – Quarter (Q1) ending 30 September 2021
downloadOpyl Appendix 4C – Quarter (Q4) ending 30 June 2021
downloadOpyl Appendix 4C – Quarter (Q3) ending 31 March 2021
downloadOpyl Appendix 4C – Quarter (Q1) ending 30 September 2020
downloadQ4 Report and Appendix 4C 2020
downloadQ3 Report and Appendix 4C 2020
downloadCorporate Governance
2021 OPL Corporate Governance Statement
downloadShare Purchase Plan Offer Booklet
downloadOpyl – 2020 Corporate Governance Statement
downloadOpyl – Audit and Risk Committee Charter 2020
downloadOpyl – Board Charter 2020
downloadOpyl – Code of Conduct (New) 2020
downloadOpyl – Diversity Policy 2020
downloadOpyl – Remuneration and Nomination Committee Charter 2020
downloadOpyl – Trading Policy (New) 2020
downloadOpyl – Whistleblower (New) 2020
downloadOpyl Disclosure and Communication Policy Update 2020
downloadBoard and Management Team
Dr Julian Chick
Chairman
Michelle Gallaher
Chief Executive Officer
Damon Rasheed
Executive Director
Marat Basyrov
Non Executive Director
Mark Ziirsen
Non Executive Director
Dr Megan Robertson
Non Executive Director
David Iilja
Company Secretary